Brickell Biotech Stock Target Price and Analyst Consensus
BBI Stock | USD 0.90 0.01 1.10% |
The current analyst and expert consensus on Brickell Biotech is Strong Buy, with 2 strong buy opinions. The current projected Brickell Biotech target price consensus is 5.00 with 2 analyst opinions. The most common way Brickell Biotech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Brickell Biotech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Brickell Biotech. We encourage you to use your own analysis of Brickell Biotech to validate this buy or sell advice. Brickell Biotech buy-or-sell recommendation module provides average expert sentiment on the projected Brickell Biotech target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Brickell Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.
Lowest Forecast 4.55 | Highest Forecast 5.55 | Target Price 5 |
Brickell |
It's important to approach Brickell Biotech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Brickell Biotech price targets
Brickell Biotech's stock target price is an estimate of its future price, usually made by analysts. Using Brickell Biotech's target price to determine if it is a suitable investment can be done through the following steps:- Look at Brickell Biotech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Brickell Biotech's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Brickell Biotech Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Brickell Biotech is a key component of Brickell Biotech valuation and have some predictive power on the future returns of a Brickell Biotech.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Brickell Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Momentum Invested a lot of shares | ||
Manufacturing Invested over 40 shares | ||
Hedge Favorites Invested over 50 shares | ||
Artificial Intelligence Invested few shares | ||
Check out Macroaxis Advice on Brickell Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Brickell Stock analysis
When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
The data published in Brickell Biotech's official financial statements usually reflect Brickell Biotech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Brickell Biotech. For example, before you start analyzing numbers published by Brickell accountants, it's critical to develop an understanding of what Brickell Biotech's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Brickell Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brickell Biotech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Brickell Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Brickell Biotech. Please utilize our Beneish M Score to check the likelihood of Brickell Biotech's management manipulating its earnings.